Based on the company’s proprietary heat inactivation technology, Stabilizor T1 stabilizes tissue from the crucial moment of sampling, permanently eliminating the activity of degradative enzymes, without the use of additives.
Dr Roland Bucher, CEO at Bucher Biotec AG says: “We are very pleased to start distributing Denator’s product line. We expect Bucher Biotec AG can provide more benefits to the protein analysis industry in Switzerland through this new relationship with Denator.”
Olof Sköld, CEO at Denator, stated: “We selected Bucher as our distribution partner in Switzerland because of their great track record and reputation. The company has established relations and years of experience from selling medical devices to our prime target groups. Selecting reputable, experienced distributors such as Bucher will help us build on the growing worldwide interest in Denator’s products and ensure that we can support protein analysis scientists at the local level."
About Bucher Biotec AG
Founded in 1978, Bucher Biotec AG is a privately held independent Swiss distributor company representing some of the most advanced US and European manufacturers of highly innovative life science research instrumentation, associated reagents and consumables. Bucher Biotec AG is extremely proud of their distinguished customer base in the pharmaceutical, biotechnology, agricultural, food and related industries, in all life science research oriented academic institutions, in numerous governmental, clinical and environmental labs and in all of the university hospitals.
Their highly competent, well educated team is focused on trying to understand their customer’s needs in order to be able to propose optimal solutions for the demanding research tasks, and in order to help to accelerate scientific exploration. For more information visit: www.bucher.ch
Bucher Biotec AG Viaduktstrasse 42 4051 Basel, Switzerland
About Denator
Denator develops and sells products that stabilize biological tissues and fluids from the moment of sampling. Stabilization and standardization of sampling processes upstream significantly enhances the quality of data obtained from analytical techniques used downstream. In proteomic and peptidomic investigations, enhanced data quality increases the reliability of data interpretation and can reveal novel proteins and peptides that would be lost or undetectable when using conventional preparation techniques. Based upon the company’s proprietary heat-inactivation technology platform, Denator is developing solutions that enable scientists to stop sample degradation instantly and maintain the stability of sample components throughout the analytical workflow. Established in 2004, Denator is headquartered at the Biotech Center in Gothenburg, Sweden. For more information visit: www.denator.com or contact:
Charlotte Emlind Vahul Business Development Denator AB E-mail: charlotte@denator.com Tel.: +46 31 41 28 41 Fax.: +46 31 41 28 40
